Gelteq (GELS) Notes Payables (2023 - 2025)
Gelteq (GELS) posted quarterly Notes Payables of $2.7 million for Q2 2025, up 96.02% year-over-year from $1.4 million in Q2 2024, and up 6.03% quarter-over-quarter from $2.5 million in Q4 2024.
Gelteq (GELS) Notes Payables (2023 - 2025) Analysis & Trends
Gelteq's Notes Payables history runs 3 years deep, the most recent figure standing at $2.7 million for Q2 2025.
- In Q2 2025, Notes Payables rose 96.02% year-over-year to $2.7 million; the TTM figure through Jun 2025 stood at $2.7 million (up 96.02% YoY), while the FY2025 annual figure was $2.7 million, up 96.02% from the prior year.
- Notes Payables for Q2 2025 stood at $2.7 million, up from $2.5 million in the prior quarter.
- The five-year high for Notes Payables was $2.7 million in Q2 2025, with the low at $3399.3 in Q2 2023.
- The 3-year median for Notes Payables is $2.0 million (2024), against an average of $1.7 million.
- The sharpest annual moves came in 2024 and 2025: Notes Payables surged 40305.81% in 2024, then soared 96.02% in 2025.
- Gelteq's Notes Payables stood at $3399.3 in 2023, then soared by 74597.21% to $2.5 million in 2024, then gained by 6.03% to $2.7 million in 2025.
- Business Quant data shows GELS's Notes Payables at $2.7 million in Q2 2025, $2.5 million in Q4 2024, and $1.4 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Gelteq | 5.85 Mn | 5.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.69 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Jun 30, 2023 | 3,399.28 |